• Early Detection of Cancer
  • Quantitative Biopsy Reading
  • Drug Discovery Optimization
  • Nanomagnetic Relaxometry is a Novel Imaging Modality
  • Comparison of Nanomagnetic Relaxometry with MRI

Senior Scientific LLC is at the crossroads of biotechnology and nanotechnology. Our novel bioimaging and nanomagnetic detection systems have been developed specifically to detect cancer and other diseases earlier and with higher specificity than is currently possible.

We have developed proprietary hardware and software for the highly sensitive detection of nanomagnetic particles that can be linked to antibodies for the detection and treatment of cancer and other human diseases—all without the use of ionizing radiation or large magnetic fields. Our novel technologies make possible the earlier detection of cancer in vivo, the ability to analyze biopsies with greater sensitivity and accuracy, the ability to monitor the therapeutic effectiveness of anticancer treatments—both in humans and in animal models—and allow us to detect cancer recurrence with significantly improved sensitivity.

Our research facilities are located at the University of New Mexico Science and Technology Park in Albuquerque, New Mexico, where we have longstanding relationships with the University of New Mexico Health Sciences Center, the Los Alamos National Laboratories, and the Center for Integrated Nanotechnology (CINT) at Sandia National Laboratory.

Senior Scientific is owned by Manhattan Scientifics, Inc., a publicly traded company dedicated to assisting scientific enterprises commercialize transformative new technologies.

Bob Proulx at NobleCon12

This video captures Senior Scientific COO Bob Proulx's address to investors at the January 2016 NobleCon meeting, where he presents the unique properties of magnetic relaxometry and explains how it can be used to catch cancer in its earliest stages, when life-saving treatments are most effective. NobleCon is an annual conference attended by investors who want to learn about the most promising new technologies and opportunities.


Join our email newsletter list.